ACC 2017: Late-Breaking Clinical Trials
Research includes safety of digoxin with atrial fibrillation, comparison of cerebral embolic protection devices, and cerebral microbleed triggers.
ACC 2017: CV Risk Factors
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Neuro News Roundup: Parkinson or parkinsonian?
Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.
ACTRIMS 2017 Forum: MS Treatment Clinical Trials
Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.
Top 10 Neurology Apps
Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.
ISC 2017: Vascular Cognitive Impairment
Research included the impact of diet on cognitive decline and the degree of a link between depression & dementia post intracerebral hemorrhage.
Interesting Neuro: Stroke Risks & Treatment
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
Neuro News Roundup: MS Biomarker & Second Stroke
Three new studies explore preventing secondary stroke, a potential biomarker for MS prediction, and a link between vitamin D and headache.
Interesting Neuro: Epilepsy Outcomes & Vitamin D
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.
By clicking Accept, you agree to become a member of the UBM Medica Community.